-
“China and Asia are already the global leaders of Antibody-drug conjugates”
31 Jan 2025 12:27 GMT
… the global leaders of Antibody-drug conjugates”
January 31, 2025 … complies with US Food and Drug Administration (FDA), European Medicines … ADC conjugation and ADC drug product manufacturers.
Although we … as we work with biotech companies to help innovative …
-
APAC takes centre-stage in AI-driven drug discovery
31 Jan 2025 12:27 GMT
… with Alphabet's digital biotech company Isomorphic Labs in January … (identifying new uses for existing drugs), drug asset management (licensing undervalued assets … drug candidates have encountered significant setbacks in 2023.
The UK-based biotech …
-
Drug Discovery Services Market Dynamics, Growth, and Opportunities by Exactitude Consultancy
31 Jan 2025 10:09 GMT
… ., Jubilant Pharmova Limited, GenScript Biotech Corporation, Oncodesign Services, and … Methodology
Market Research Methodology of Drug Discovery Services: The market … Neurology
Infectious
Regional Analysis for Drug Discovery Services Market:
◘ North …
-
Cell-Based Assays Market To Reach US$ 37.1 Billion By 2032, Driven By Increasing Demand In Drug Discovery
31 Jan 2025 09:48 GMT
… increasing demand for efficient drug screening techniques, personalized medicine … By Application
•Basic Research
•Drug Discovery
•Toxicity Studies
•Pharmacodynamic … End-Users
Pharmaceutical & Biotechnology Companies
Contract Research Organizations …
-
Chinese biotech firms cash in on promising drug discoveries via licensing deals
31 Jan 2025 09:01 GMT
Licensing deals struck by Chinese biotech start-ups with overseas … in revenue if their drug candidates are successfully developed … on January 21
New drugs typically take a decade … -licensing typically involves a drug discoverer and patent owner selling …
-
Maze and Metsera biotech IPOs to begin trading Friday
31 Jan 2025 08:44 GMT
Obesity drug developer Metsera and kidney disease biotech Maze Therapeutics priced their Nasdaq …
-
Hereditary Angioedema Drug Market Expansion Forecasted at X% CAGR to X Billion USD by 2032 | Argenx, Shire ,CSL Behring
31 Jan 2025 08:08 GMT
… AI, robotics, and biotechnology. AI is enhancing … 𝖣𝖾𝗍𝖺𝗂𝗅𝖾𝖽 𝖲𝖾𝗀𝗆𝖾𝗇𝗍𝖺𝗍𝗂𝗈𝗇:
Hereditary Angioedema Drug Market Segmentation Insights
Hereditary Angioedema … #47;reports/hereditary-angioedema-drug-market
𝖮𝗍𝗁𝖾𝗋 𝖫𝖺𝗍𝖾𝗌𝗍 𝖧𝖾𝖺𝗅𝗍𝗁𝖼𝖺𝗋𝖾 𝖳𝗋𝖾𝗇𝖽𝗂𝗇𝗀 𝖨𝗇𝗌𝗂𝗀𝗁𝗍𝗌
…
-
Multiple Sclerosis Ms Drugs Market Growth at 7.15% CAGR, Surpassing 56.5 Billion USD by 2032
31 Jan 2025 08:08 GMT
… Sclerosis Ms Drugs Market Industry Overview 2025 By Drug Class (Disease … such as AI, robotics, and biotechnology. AI is enhancing diagnostics, … Sclerosis Ms Drugs MarketProduct TypeOutlook
Generic Drugs
Branded Drugs
Biosimilars
Multiple …
-
Human Microbiome Based Drugs Diagnostics Market Growth at a CAGR of 19.03% to Hit 85.7 Billion USD by 2032 | EMD Serono
31 Jan 2025 07:40 GMT
… between biotech firms and research institutions.
Top Human Microbiome Based Drugs Diagnostics … such as AI, robotics, and biotechnology. AI is enhancing diagnostics, decision … computing holds potential for advancing drug discovery and managing complex data …
-
An Injectable Hydrogel Bioimplant Loaded with Engineered Exosomes and Triple Anti-Tuberculosis Drugs with Potential for Treating Bone and Joint Tuberculosis
31 Jan 2025 06:09 GMT
… Biotech Co., Ltd, China.
Preparation and Characterization of Liposomes
Liposomes and drug … drugs relative to free drugs.79 To extend duration of drug … et al. Instant hydrogelation encapsulates drugs onto implants intraoperatively against osteoarticular …
About
© 1995-2025